home / stock / hqh / hqh news


HQH News and Press, Tekla Healthcare Investors From 03/09/23

Stock Information

Company Name: Tekla Healthcare Investors
Stock Symbol: HQH
Market: NYSE

Menu

HQH HQH Quote HQH Short HQH News HQH Articles HQH Message Board
Get HQH Alerts

News, Short Squeeze, Breakout and More Instantly...

HQH - FCEF: A Fund Of Funds Beating Competitors

2023-03-09 05:23:39 ET Summary First Trust CEF Income Opportunity ETF is an actively managed fund of funds. It has outperformed its competitors YYY and PCEF since 2016. Distribution growth has outpaced inflation, but share price has lagged it. The main issues of this fund ...

HQH - HQH: Higher Risk Healthcare CEF

2023-03-05 07:56:14 ET Summary The HQH fund aims to provide high total returns through investments in the healthcare industry. HQH has a high allocation to risky biotech stocks and private investments. The fund pays a 2% of NAV quarterly distribution. However, HQH has under-earned...

HQH - Buy The Dip - 2 Dividends At Bargain Prices

Summary CEFs trend towards a reversion to mean over time. We find two funds trading outside of their normal discount/premium. One of our picks gives high levels of tax-free income. Co-produced with Treading Softly. For years you have been surrounded by forces of na...

HQH - Tekla Healthcare Investors raises dividend by 7.7% to $0.42

Tekla Healthcare Investors ( NYSE: HQH ) declares $0.42/share quarterly dividend , 7.7% increase from prior dividend of $0.39. Forward yield 8.97% Payable March 31; for shareholders of record Feb. 27; ex-div Feb. 24. See HQH Dividend Scorecard, Yield Chart, &...

HQH - Ascendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral Rating

Summary Ascendis is a mid-cap commercial biotech based in Denmark. Currently, it trades around $6.7B market cap, and the company holds $900M cash. Skytrofa (TransCon hGh) is Ascendis' lead approved agent for pediatric growth hormone deficiency (GHD), where the commercial update was luke...

HQH - 2 Big Fat Dividends I'm Buying Hand Over Fist

Summary Many dividend investments remain oversold and are great opportunities. I invest for income and it allows me to control my retirement outlook. We look at two excellent opportunities. Co-produced with Treading Softly. The famous Charles Dickens book, A Tale...

HQH - The 8% Income Portfolio: 2022 Year-End Review

Summary Presenting our 2022 year-end review of our 8% Income Portfolio. This high-income portfolio earned over $29,000 in distributions (including year-end special distributions) amounting to over 14% yield-on-cost basis. The portfolio had a loss of -12.5% in 2022, compared to -18.2...

HQH - How To Use CEFs For A Rich Retirement

Summary Closed-end funds are great income investments thanks to tax laws and tradition. Being required to pay out most of their taxable gains explains a lot about how CEFs act. CEFs can be great income investments. Co-produced with Beyond Saving. Introduction W...

HQH - Equity CEFs: Top Picks For 2023

Summary 2022 was a year to forget, while most believe 2023 will begin with the same issues that took the equity and bond markets well into bear market territory last year. That is, a hawkish Federal Reserve that doesn't want to let up on strangling inflation into submission while draini...

HQH - HQH: 50 Big-Yield Healthcare Stocks, These 3 Worth Considering

Summary We share data on over 50 big-yield healthcare investments, including individual stocks, REITs, closed-end funds ("CEFs") and bonds. We dive deeper into three specific attractive big-yield opportunities that also have healthy upside potential. We begin with a special focus on...

Previous 10 Next 10